602 related articles for article (PubMed ID: 20471712)
21. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
[TBL] [Abstract][Full Text] [Related]
22. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.
Cohen SJ; Punt CJ; Iannotti N; Saidman BH; Sabbath KD; Gabrail NY; Picus J; Morse M; Mitchell E; Miller MC; Doyle GV; Tissing H; Terstappen LW; Meropol NJ
J Clin Oncol; 2008 Jul; 26(19):3213-21. PubMed ID: 18591556
[TBL] [Abstract][Full Text] [Related]
23. Elevated activities of MMP-2 in the non-tumorous lung tissues of curatively resected stage I NSCLC patients are associated with tumor recurrence and a poor survival.
Kim SH; Choi HY; Lee J; Son DS; Lee HS; Song IS; Lim YS; Hong YS; Kim J; Choi YS
J Surg Oncol; 2007 Mar; 95(4):337-46. PubMed ID: 17326127
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of detecting survivin-expressing circulating cancer cells in patients with non-small cell lung cancer.
Yie SM; Lou B; Ye SR; He X; Cao M; Xie K; Ye NY; Lin R; Wu SM; Xiao HB; Gao E
Lung Cancer; 2009 Feb; 63(2):284-90. PubMed ID: 18606477
[TBL] [Abstract][Full Text] [Related]
25. Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker.
Hofman V; Bonnetaud C; Ilie MI; Vielh P; Vignaud JM; Fléjou JF; Lantuejoul S; Piaton E; Mourad N; Butori C; Selva E; Poudenx M; Sibon S; Kelhef S; Vénissac N; Jais JP; Mouroux J; Molina TJ; Hofman P
Clin Cancer Res; 2011 Feb; 17(4):827-35. PubMed ID: 21098695
[TBL] [Abstract][Full Text] [Related]
26. Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies.
Bonmassar L; Fossile E; Scoppola A; Graziani G; Prete SP; Formica V; Cappelletti D; De Vecchis L; Cardillo A; Concolino F; D'Atri S; Balduzzi A; Torino F; Caporaso P; Greiner JW; Bonmassar E; Roselli M; Aquino A
Anticancer Res; 2010 Nov; 30(11):4721-30. PubMed ID: 21115931
[TBL] [Abstract][Full Text] [Related]
27. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.
Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H
Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150
[TBL] [Abstract][Full Text] [Related]
28. Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients.
Tokudome N; Ito Y; Takahashi S; Kobayashi K; Taira S; Tsutsumi C; Oto M; Oba M; Inoue K; Kuwayama A; Masumura K; Nakayama Y; Watanabe C; Hatake K
Breast Cancer; 2011 Jul; 18(3):195-202. PubMed ID: 21465230
[TBL] [Abstract][Full Text] [Related]
29. Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.
Yu XM; Wu YC; Liu X; Huang XC; Hou XX; Wang JL; Cheng XL; Mao WM; Ling ZQ
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827952
[TBL] [Abstract][Full Text] [Related]
30. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
[TBL] [Abstract][Full Text] [Related]
31. Associations of deregulation of mir-365 and its target mRNA TTF-1 and survival in patients with NSCLC.
Sun R; Liu Z; Ma G; Lv W; Zhao X; Lei G; Xu C
Int J Clin Exp Pathol; 2015; 8(3):2392-9. PubMed ID: 26045746
[TBL] [Abstract][Full Text] [Related]
32. Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer.
Ignatiadis M; Perraki M; Apostolaki S; Politaki E; Xenidis N; Kafousi M; Stathopoulos E; Lianidou E; Sotiriou C; Georgoulias V; Mavroudis D
Clin Breast Cancer; 2007 Dec; 7(11):883-9. PubMed ID: 18269779
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of chemotherapy-resistant CK19mRNA-positive circulating tumor cells in patients with advanced/metastatic non-small cell lung cancer.
Milaki G; Messaritakis I; Koinis F; Kotsakis A; Apostolaki S; Dermitzaki EK; Perraki M; Hatzidaki D; Georgoulias V
Cancer Chemother Pharmacol; 2017 Jul; 80(1):101-108. PubMed ID: 28523597
[TBL] [Abstract][Full Text] [Related]
34. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
Takanami I
Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511
[TBL] [Abstract][Full Text] [Related]
36. Novel approach for detection of isolated tumor cells in pulmonary vein using negative selection method: morphological classification and clinical implications.
Funaki S; Sawabata N; Nakagiri T; Shintani Y; Inoue M; Kadota Y; Minami M; Okumura M
Eur J Cardiothorac Surg; 2011 Aug; 40(2):322-7. PubMed ID: 21215651
[TBL] [Abstract][Full Text] [Related]
37. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
39. Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer.
Kim JS; Kim JW; Han J; Shim YM; Park J; Kim DH
Cancer Res; 2006 Apr; 66(8):4049-54. PubMed ID: 16618724
[TBL] [Abstract][Full Text] [Related]
40. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].
Zheng HY; Chen Q; Ye YB; Huang WW
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2267-70. PubMed ID: 19087676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]